Status:
RECRUITING
Efficacy of Steroid Injection in Patients With Bifid Median Nerve Diagnosed Carpal Tunnel Syndrome
Lead Sponsor:
Yunus Burak Bayır
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Various median nerve anatomical variations have been reported in the literature.One of these is the bifid median nerve.Due to its relatively higher cross-sectional area, it can facilitate compression ...
Detailed Description
Our study was designed as a prospective, double-blind randomized controlled study.Patients with an electrophysiological diagnosis of moderate CTS who applied to Etlik City Hospital Physical Therapy ou...
Eligibility Criteria
Inclusion
- Being between the ages of 18-65
- Being clinically diagnosed with Carpal Tunnel Syndrome
- Confirmation of mild and moderate Carpal Tunnel Syndrome diagnosis with EMG
- Diagnosis of bifid median nerve after ultrasound evaluation, No variation was detected for the control group either.
- Having typical Carpal Tunnel Syndrome symptoms for at least 3 months
Exclusion
- History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or wrist surgery
- History of Inflammatory arthritis, hypothyroidism, pregnancy,rheumatological disorders or heart battery
- current warfarin use, Prior steroid injection for CTS, trauma or neoplasm at the injection site, hypersensitivity to corticosteroids or skin infection at the injection site
- other median nerve variations and presence of persistent median artery.
Key Trial Info
Start Date :
September 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 14 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06599086
Start Date
September 15 2024
End Date
September 14 2025
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etlik City Hospital
Ankara, Ankara, Turkey (Türkiye), 06170